$95.00
Ipamorelin is a selective pentapeptide growth hormone secretagogue and ghrelin receptor (GHSR) agonist. Unlike other GH secretagogues, ipamorelin demonstrates high selectivity, stimulating growth hormone release without significantly affecting cortisol, prolactin, or ACTH levels. This selective profile makes it a preferred research tool for studying growth hormone physiology.
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
These products are for laboratory research only and not intended for medical use. They must be handled by qualified professionals in controlled laboratory environments. This compound has not been evaluated by the FDA and is not approved for human or veterinary use.
Third-party tested for purity, identity, and quantity.
VL-6499787
This ipamorelin is supplied as a lyophilized (freeze-dried) white powder at ≥98% purity as determined by HPLC analysis and confirmed by mass spectrometry. A certificate of analysis (CoA) is provided with each lot, detailing purity, molecular weight confirmation, and sterility testing results. This product is manufactured for research laboratory use only.
Lyophilized ipamorelin should be stored at −20°C in a desiccated, sealed environment protected from light and moisture. Under these conditions, shelf stability is expected to be 24 months or longer. Repeated freeze-thaw cycles should be avoided after reconstitution; researchers are advised to prepare single-use aliquots when possible.
For research purposes, ipamorelin is commonly reconstituted in sterile, bacteriostatic water or 0.9% saline, depending on the experimental protocol. The peptide is freely soluble in aqueous vehicles at typical research working concentrations. Reconstituted solutions should be aliquoted and stored at −80°C to maintain integrity, and researchers should consult their institutional protocols for handling reconstituted peptides.
No. This product is supplied exclusively for in vitro laboratory research and preclinical in vivo animal studies conducted by qualified researchers. It is not approved by any regulatory authority for human or veterinary therapeutic use, and it must not be administered to humans under any circumstances.
Published preclinical research has employed ipamorelin in rat and mouse pituitary cell cultures to assess GH secretion, as well as in whole-animal rodent models examining bone growth, GI motility, and GH axis dynamics. Cell-based receptor binding assays using GHSR-1a-expressing recombinant cell lines have also been used to characterize its pharmacological selectivity relative to other GHSR agonists.
Ipamorelin’s primary molecular target is the growth hormone secretagogue receptor type 1a (GHSR-1a), the endogenous receptor for ghrelin. It functions as a GHSR-1a agonist, stimulating GH release from somatotroph cells. Research suggests it has negligible affinity for cortisol, ACTH, or prolactin pathways at GH-stimulating concentrations, distinguishing its receptor selectivity profile from earlier-generation GHRPs in comparative pharmacology studies.
Scientific research has identified several key areas where Ipamorelin shows promising applications.
These research findings represent ongoing studies and should not be interpreted as medical claims or recommendations.
These references are provided for research purposes only. Citations do not imply endorsement or approval of this product for any specific application.
$120.00
